key: cord-0731287-kmznat8v
authors: Zhang, Shihai; Pei, Rongjuan; Li, Meixia; Sun, Hao; Su, Minbo; Ding, Yaqi; Chen, Xia; Du, Zhenyun; Jin, Can; Huang, Chunfan; Zang, Yi; Li, Jia; Xu, Yechun; Chen, Xinwen; Zhang, Bo; Ding, Kan
title: Structural characterization of cocktail-like targeting polysaccharides from Ecklonia kurome Okam and their anti-SARS-CoV-2 activities invitro
date: 2021-01-15
journal: bioRxiv
DOI: 10.1101/2021.01.14.426521
sha: f4bc6e073e88df73733b740077ea740355d30739
doc_id: 731287
cord_uid: kmznat8v

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiological agent responsible for the worldwide coronavirus disease 2019 (COVID-19) outbreak. Investigation has confirmed that polysaccharide heparan sulfate can bind to the spike protein and block SARS-CoV-2 infection. Theoretically, similar structure of nature polysaccharides may also have the impact on the virus. Indeed, some marine polysaccharide has been reported to inhibit SARS-Cov-2 infection in vitro, however the convinced targets and mechanism are still vague. By high throughput screening to target 3CLpro enzyme, a key enzyme that plays a pivotal role in the viral replication and transcription using nature polysaccharides library, we discover the mixture polysaccharide 375 from seaweed Ecklonia kurome Okam completely block 3Clpro enzymatic activity (IC50, 0.48 µM). Further, the homogeneous polysaccharide 37502 from the 375 may bind to 3CLpro molecule well (kD value : 4.23 × 10−6). Very interestingly, 37502 also can potently disturb spike protein binding to ACE2 receptor (EC50, 2.01 µM). Importantly, polysaccharide 375 shows good anti-SARS-CoV-2 infection activity in cell culture with EC50 values of 27 nM (99.9% inhibiting rate at the concentration of 20 µg/mL), low toxicity (LD50: 136 mg/Kg on mice). By DEAE ion-exchange chromatography, 37501, 37502 and 37503 polysaccharides are purified from native 375. Bioactivity test show that 37501 and 37503 may impede SARS-Cov-2 infection and virus replication, however their individual impact on the virus is significantly less that of 375. Surprisingly, polysaccharide 37502 has no inhibition effect on SARS-Cov-2. The structure study based on monosaccharide composition, methylation, NMR spectrum analysis suggest that 375 contains guluronic acid, mannuronic acid, mannose, rhamnose, glucouronic acid, galacturonic acid, glucose, galactose, xylose and fucose with ratio of 1.86 : 9.56 : 6.81 : 1.69 : 1.00 : 1.75 : 1.19 : 11.06 : 4.31 : 23.06. However, polysaccharide 37502 is an aginate which composed of mannuronic acid (89.3 %) and guluronic acid (10.7 %), with the molecular weight (Mw) of 27.9 kDa. These results imply that mixture polysaccharides 375 works better than the individual polysaccharide on SARS-Cov-2 may be the cocktail-like polysaccharide synergistic function through targeting multiple key molecules implicated in the virus infection and replication. The results also suggest that 375 may be a potential drug candidate against SARS-CoV-2.

Investigation has confirmed that polysaccharide heparan sulfate can bind to the spike 26 protein and block SARS-CoV-2 infection. Theoretically, similar structure of nature 27 polysaccharides may also have the impact on the virus. Indeed, some marine 28 polysaccharide has been reported to inhibit SARS-Cov-2 infection in vitro, however 29 the convinced targets and mechanism are still vague. By high throughput screening to 30 target 3CLpro enzyme, a key enzyme that plays a pivotal role in the viral replication 31 and transcription using nature polysaccharides library, we discover the mixture In this study, we firstly extracted crude polysaccharide, named 375 from 116 Ecklonia kurome and examine the bioactivity against SARS-Cov-2 virus. Then we 117 isolated and purified crude polysaccharide and further characterized the structure of 118 one homogeneous polysaccharide 37502 from Ecklonia kurome. The molecular 119 weight (Mw), monosaccharide composition, infrared spectroscopy (IR) and nuclear 120 magnetic resonance (NMR) spectra were employed to analyze the structure. 121 Eventually, we further examined anti-SARS-CoV-2 bioactivity by targeting 3CL pro, 122 S1 and ACE2 molecules. HMBC spectrum was employed to analyze the structure backbone and the 202 substitution sites. In showed that 375 might potently inhibit SARS-CoV-2 3CLpro activity (Fig. 7) . Further whether it might disturb the binding between S1 protein and ACE2 by ELISA method. 277 The results showed that polysaccharide 37502 could effectively impede the binding of 278 S1 protein with ACE2. The median inhibitory concentration (IC50) was 56.06 µg/mL 279 (Fig. 8B) . This result suggested that 37502 might had the potential to block 280 SARS-Cov-2 infection through disturbing the S protein binding to ACE2 receptor. The result showed that polysaccharide 37501 and 37503 exhibited antivirus effect on 297 SARS-CoV-2 (Fig. 9B) . Although 37502 might attenuate 3CLpro enzymatic activity 298 significantly (Fig. 8A) , it had no significant direct effect against the active virus 299 replication (Fig. 9B) . To examine whether purified polysaccharide 37503 have 300 stronger bioactivity than that of native polysaccharide 375, EC50 of 37503 against 301 SARS-Cov-2 was also measured. Interestingly, effect of 37503 is significant feeble 302 than that of 375, while EC50 of 37503 is 0.89 µM (or 11.07 µg/mL) (Fig. 9C) . This China). Uronic acid content was determined by the meta-hydroxydiphenyl method 329 using galacturonic acid as a standard. All the measurements were repeated three times. 330 Novostar microplate reader was employed to detect the absorbance at OD490 for sugar, 331 OD520 for uronic acid and OD562 for protein. 353 The IR spectra was determined according to the previous report ( Uronic acid reduction 377 The method was based on the reported method (Taylor & Conrad, 1972 

Remdesivir for the treatment of Covid-19 -final report

SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2

Structure and biological activities of an 448 alginate from Sargassum fusiforme, and its sulfated derivative

Sugar compositional 451 determination of polysaccharides from Dunaliella salina by modified RP-HPLC method of 452 precolumn derivatization with 1-phenyl-3-methyl-5-pyrazolone

In vivo growth-inhibition of Sarcoma 180 tumor by alginates from 456 brown seaweed Sargassum vulgare

A role for quercetin in coronavirus 459 disease 2019 (COVID-19)

An interactive web-based dashboard to track COVID-19 in 462 real time

Colorimetric method for 465 determination of sugar and related substances

An influence of the structure of alginate on the chemotactic 468 activity of macrophages and the antitumor activity

NMR spectroscopy 471 analysis of oligoguluronates and oligomannuronates prepared by acid or enzymatic hydrolysis 472 of homopolymeric blocks of alginic acid. Application to the determination of the substrate 473 specificity of Haliotis tuberculata alginate lyase

Pre-fusion structure of a human coronavirus spike protein

Varieties of antioxidant and antibacterial 479 properties of Ecklonia stolonifera and Ecklonia kurome products harvested and processed in 480 the Noto peninsula

Structural, 483 glycosylation and antigenic variation between 2019 novel coronavirus (2019-nCoV) and 484 SARS coronavirus

Structure of the SARS-CoV-2 spike 487 receptor-binding domain bound to the ACE2 receptor

The efficacy of Chinese medicine for SARS: a review of Chinese publications 490 after the crisis

Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus

Purification, characterization 496 and anti-tumor activities of polysaccharides from Ecklonia kurome obtained by three different 497 extraction methods

The influence of 500 molecular mass of sulfated propylene glycol ester of low-molecular-weight alginate on 501 anticoagulant activities

Proteoglycans and Sulfated

Improving the in vivo bioavailability and in 507 vitro anti-inflammatory activity of tanshinone IIA by alginate solid dispersion

Can 511 Chinese medicine be used for prevention of corona virus disease 2019 (COVID-19)? A 512 Review of Historical Classics, Research Evidence and Current Prevention Programs

Preliminary studies on the chemical 515 characterization and antihyperlipidemic activity of polysaccharide from the brown alga 516 Sargassum fusiforme

Human 519 coronavirus NL63 utilizes heparan sulfate proteoglycans for attachment to target cells

Deducing the N-and O-glycosylation 522 profile of the spike protein of novel coronavirus SARS-CoV-2

Monomer composition and 525 sequence of alginates from Pseudomonas aeruginosa

Inhibitory activities of marine 528 sulfated polysaccharides against SARS-CoV-2

Anti-SARS-CoV-2 531 activities in vitro of Shuanghuanglian preparations and bioactive ingredients

Stoichiometric depolymerization of polyuronides and

Traditional 538

Chinese medicine herbal extracts of Cibotium barometz, Gentiana scabra, Dioscorea batatas

Cassia tora, and Taxillus chinensis inhibit SARS-CoV replication

Production of Authentic 542 SARS-CoV Mpro with Enhanced Activity: Application as a Novel Tag-cleavage

Endopeptidase for Protein Overproduction

Design of wide-spectrum 546 inhibitors targeting coronavirus main proteases

The crystal structures of severe 549 acute respiratory syndrome virus main protease and its complex with an inhibitor

Structural basis for 553 inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir